Answers are grounded in this paper and cite their sources.
Background As the global population ages, the number of people living with dementia is rising rapidly, creating substantial economic challenges for healthcare systems, caregivers, and societies worldwide. Objective We examined the economics of dementia care across five developed countries to identify potentially transferable care practices and policy approaches relevant to the U.S. Methods We conducted a scoping review of studies involving adults with dementia that assessed dementia care, healthcare utilization, or costs in Canada, France, Germany, China, and Japan. Searches were performed in Ovid MEDLINE and Ovid Embase for January 2017–December 2023. Results Of 12,286 titles and abstracts screened, 266 articles underwent full-text review, and 63 met inclusion criteria. Studies were categorized into three areas: prescription drug use, direct medical costs, and economic impacts of care models or policies. We found that use of antidementia medications generally decreases with increasing dementia severity. Higher severity and greater burden of comorbidity were associated with increased costs, largely driven by frequent hospitalizations and long-term care. Policies incentivizing informal caregiving were associated with delayed long-term care but may reduce caregivers’ labor-force participation, while in-kind, service-based models showed more consistent evidence of delaying costly institutional care. Evidence on integrated care models was mixed. Conclusions Rising dementia-related healthcare costs in aging populations represent a shared global challenge. Aligning reimbursement policies, care models, and service delivery with disease severity and care needs can improve efficiency, equity, and sustainability.
No takes yet. Share an insight, caveat, or question.
Gurney et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: